The estimated Net Worth of Daniel J Bevevino is at least $1 Milhão dollars as of 5 May 2011. Mr. Bevevino owns over 10,000 units of Artivion Inc stock worth over $804,600 and over the last 21 years he sold CRY stock worth over $0. In addition, he makes $195,015 as Independent Director at Artivion Inc.
Daniel has made over 3 trades of the Artivion Inc stock since 2004, according to the Form 4 filled with the SEC. Most recently he exercised 10,000 units of CRY stock worth $50,000 on 5 May 2011.
The largest trade he's ever made was exercising 31,499 units of Artivion Inc stock on 28 January 2004 worth over $873,782. On average, Daniel trades about 2,798 units every 102 days since 2004. As of 5 May 2011 he still owns at least 45,000 units of Artivion Inc stock.
You can see the complete history of Mr. Bevevino stock trades at the bottom of the page.
Daniel J. Bevevino is an Independent Director of CryoLife, Inc., Mr. Bevevino has served as a director of CryoLife since December 2003. From 1996 until March 2008, Mr. Bevevino served as the Vice President and Chief Financial Officer of Respironics, Inc., a company that developed, manufactured and marketed medical devices used primarily for the treatment of patients suffering from sleep and respiratory disorders. He was employed by Respironics beginning in 1988. In March 2008, Respironics was acquired by Royal Philips Electronics (NYSE: PHG) (“Philips”), whose businesses included a variety of medical solutions including medical diagnostic imaging and patient monitoring systems, as well as businesses focused on energy efficient lighting and consumer products. From March 2008 to December 31, 2009, Mr. Bevevino was employed by Philips as the Head of Post-Merger Integration – Respironics, as well as in various operating capacities, to help facilitate the integration of the combined companies. He is currently an independent consultant providing interim chief financial officer services in the life sciences industry, and he currently serves as a director of one of the private companies for which he provides services. He began his career as a Certified Public Accountant with Ernst & Young LLP. Mr. Bevevino’s license is currently inactive. Mr. Bevevino received a B.S. in Business Administration from Duquesne University and an MBA from the University of Notre Dame.
As the Independent Director of Artivion Inc, the total compensation of Daniel Bevevino at Artivion Inc is $195,015. There are 10 executives at Artivion Inc getting paid more, with James Mackin having the highest compensation of $6,453,540.
Daniel Bevevino is 60, he's been the Independent Director of Artivion Inc since 2003. There are 7 older and 16 younger executives at Artivion Inc. The oldest executive at Artivion Inc is Ronald McCall, 83, who is the Presiding Independent Director.
Over the last 21 years, insiders at Artivion Inc have traded over $18,346,910 worth of Artivion Inc stock and bought 91,700 units worth $1,086,548 . The most active insiders traders include Steven G Anderson, Thomas F Ackerman, eJames P Mackin. On average, Artivion Inc executives and independent directors trade stock every 26 days with the average trade being worth of $211,842. The most recent stock trade was executed by Amy Horton on 8 December 2021, trading 2,500 units of CRY stock currently worth $46,425.
Headquartered in suburban Atlanta, Georgia, CryoLife is a leader in the manufacturing, processing, and distribution of medical devices and implantable tissues used in cardiac and vascular surgical procedures focused on aortic repair. CryoLife markets and sells products in more than 100 countries worldwide.
Artivion Inc executives and other stock owners filed with the SEC include: